Introduction: In just two decades Acinetobacter baumannii has attained considerable importance, evolving from an insignificant organism to a leading pathogen especially in intensive care unit settings globally. Treatment options are already very limited and have almost run out due to the rapid emergence of antimicrobial resistance. Evaluation of antimicrobials that are currently in use to determine their effectiveness against multidrug-resistant (MDR) strains and developing newer options is of utmost importance. We thus set out to determine the efficacy of routinely used antibiotics against MDR A. baumannii.

中文翻译：

---

抗菌药物对三级医院患者耐多重耐药鲍曼不动杆菌的功效。

简介：在短短的二十年中，鲍曼不动杆菌已变得相当重要，从微不足道的生物演变成主要病原体，尤其是在全球重症监护病房中。治疗选择已经非常有限，并且由于抗菌素耐药性的迅速出现而几乎用完了。评估目前用于确定其抗多药耐药性（MDR）菌株的有效性并开发新的选择方案的抗生素至关重要。因此，我们着手确定常规使用的抗MDR鲍曼不动杆菌的功效。